Significant shareholders

As at 18 April 2019, shareholders holding more than 3% of the share capital of Tissue Regenix Group Plc are:

Name of Shareholder % of Voting Rights
Invesco Limited 28.76
Woodford Investment Management LLP 26.23
IP Group 13.74
Baillie Gifford & Co Ltd 6.03
Jupiter Asset Management 5.96
Directors & Related Holdings 4.31

Shares not in public hands as at 19 February 2019 – 856,002,530 - 73%

Shares in issue as at 19 February 2019 - 1,171,730,823 ordinary shares of 0.5p each

The securities of Tissue Regenix Group plc are traded on the AIM market operated by the London Stock Exchange plc. Its shares have not been admitted, nor have any applications been made, for any of its shares to be admitted or traded on any other exchanges or trading platform.

Key Advisors

    • 150 Cheapside, 
      EC2V 6ET 

    • Central Square,
      29 Wellington St,
      LS1 4DL

    • 701 Fifth Avenue, Suite 7000

      Seattle, Washington


      United States

    • 4 Beckenham Rd,
      BR3 4TU